Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joel Wight

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Leukemia & Lymphoma|November 24, 2025
Effective management of daratumumab-induced cytopenias with hematopoietic stem cell infusion in relapsed/refractory multiple myeloma: a case reportOlivia Slogrove, Joel Wight
Blood Reviews|March 23, 2025
Low flow: Selecting a limited flow cytometry panel where resources are constrainedAilie Ross, Donna Rudd, Joel Wight
BMJ Case Reports|January 11, 2023
Coagulopathy is an under-recognised complication of acquired HLHSerena Kosciejew, Edward Morris, Joel Wight
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|August 26, 2022
Case of the disappearing drusenAli S Haider, Joel Wight, Ian C Reddie
Ejhaem|July 9, 2025
T-Cell Receptor Repertoires Show Dynamic Variation Between Diagnosis and Relapse of Diffuse Large B-Cell LymphomaJoel Wight, Tom Witkowski, Colm Keane, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 22, 2018
Dapsone safety in hematology patients: Pathways to optimizing Pneumocystis jirovecii pneumonia prophylaxis in hematology malignancy and transplant recipientsKaren F Urbancic, Daisy Pisasale, Joel Wight, et al.
Pathology|August 12, 2018
Correlation of mutation status and morphological changes in essential thrombocythaemia and myelofibrosisChong Chyn Chua, Amanda Omerod, Joel Wight, et al.
Leukemia & Lymphoma|May 16, 2022
Toxicity associated with high-dose intravenous methotrexate for hematological malignanciesJoel Wight, Matthew Ku, Melissa Garwood, et al.
European Journal of Haematology|July 9, 2021
Predicting primary treatment failure using interim FDG-PET scanning in diffuse large B-cell lymphomaJoel Wight, Shin Hnin Wai, Edward Shen, et al.
Internal Medicine Journal|December 20, 2021
Diagnosis and management of primary central nervous system lymphoma: a consensus practice statement from the Australasian Lymphoma AllianceColm Keane, Nada Hamad, Allison Barraclough, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Leukemia & Lymphoma|November 24, 2025
Effective management of daratumumab-induced cytopenias with hematopoietic stem cell infusion in relapsed/refractory multiple myeloma: a case reportOlivia Slogrove, Joel Wight
Blood Reviews|March 23, 2025
Low flow: Selecting a limited flow cytometry panel where resources are constrainedAilie Ross, Donna Rudd, Joel Wight
BMJ Case Reports|January 11, 2023
Coagulopathy is an under-recognised complication of acquired HLHSerena Kosciejew, Edward Morris, Joel Wight
Canadian Journal of Ophthalmology. Journal Canadien D'Ophtalmologie|August 26, 2022
Case of the disappearing drusenAli S Haider, Joel Wight, Ian C Reddie
Ejhaem|July 9, 2025
T-Cell Receptor Repertoires Show Dynamic Variation Between Diagnosis and Relapse of Diffuse Large B-Cell LymphomaJoel Wight, Tom Witkowski, Colm Keane, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|July 22, 2018
Dapsone safety in hematology patients: Pathways to optimizing Pneumocystis jirovecii pneumonia prophylaxis in hematology malignancy and transplant recipientsKaren F Urbancic, Daisy Pisasale, Joel Wight, et al.
Pathology|August 12, 2018
Correlation of mutation status and morphological changes in essential thrombocythaemia and myelofibrosisChong Chyn Chua, Amanda Omerod, Joel Wight, et al.
Leukemia & Lymphoma|May 16, 2022
Toxicity associated with high-dose intravenous methotrexate for hematological malignanciesJoel Wight, Matthew Ku, Melissa Garwood, et al.
European Journal of Haematology|July 9, 2021
Predicting primary treatment failure using interim FDG-PET scanning in diffuse large B-cell lymphomaJoel Wight, Shin Hnin Wai, Edward Shen, et al.
Internal Medicine Journal|December 20, 2021
Diagnosis and management of primary central nervous system lymphoma: a consensus practice statement from the Australasian Lymphoma AllianceColm Keane, Nada Hamad, Allison Barraclough, et al.
Pageof 3